Marek Wloch

747 total citations
16 papers, 634 citations indexed

About

Marek Wloch is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marek Wloch has authored 16 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Marek Wloch's work include Bone health and treatments (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Genetic factors in colorectal cancer (3 papers). Marek Wloch is often cited by papers focused on Bone health and treatments (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Genetic factors in colorectal cancer (3 papers). Marek Wloch collaborates with scholars based in United States, Canada and United Kingdom. Marek Wloch's co-authors include Richard Jove, Roy Garcia, Weiguang Mao, Timothy J. Yeatman, Rosalyn Irby, Alan Cantor, Peter Vadas, Ling Fu, Domenico Coppola and Joel G. Turner and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Marek Wloch

15 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Wloch United States 10 341 289 126 111 57 16 634
S. M. LUDEMAN United States 9 380 1.1× 275 1.0× 88 0.7× 114 1.0× 93 1.6× 12 730
Yoshihiko Akama Japan 12 357 1.0× 390 1.3× 160 1.3× 97 0.9× 53 0.9× 14 698
Llorenç Coll-Mulet Spain 11 452 1.3× 263 0.9× 67 0.5× 93 0.8× 90 1.6× 12 663
Jean‐Claude Marshall United States 18 440 1.3× 251 0.9× 94 0.7× 87 0.8× 118 2.1× 31 782
Orsolya Csuka Hungary 17 351 1.0× 283 1.0× 77 0.6× 127 1.1× 34 0.6× 48 713
Eddy S. Leman United States 13 315 0.9× 184 0.6× 91 0.7× 106 1.0× 44 0.8× 21 542
Ann‐Christin Buckendahl Germany 12 747 2.2× 307 1.1× 108 0.9× 191 1.7× 33 0.6× 14 970
Kyoung Eun Baek South Korea 13 432 1.3× 218 0.8× 54 0.4× 109 1.0× 67 1.2× 18 633
Ruri Ohki Japan 13 365 1.1× 153 0.5× 120 1.0× 133 1.2× 92 1.6× 18 743
Merete Bjørnslett Norway 11 292 0.9× 238 0.8× 118 0.9× 121 1.1× 50 0.9× 20 530

Countries citing papers authored by Marek Wloch

Since Specialization
Citations

This map shows the geographic impact of Marek Wloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Wloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Wloch more than expected).

Fields of papers citing papers by Marek Wloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Wloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Wloch. The network helps show where Marek Wloch may publish in the future.

Co-authorship network of co-authors of Marek Wloch

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Wloch. A scholar is included among the top collaborators of Marek Wloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Wloch. Marek Wloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Aguirre, Luis E., Jiqiang Yao, Tania Mesa, et al.. (2022). Transcriptomic analyses of esophageal cancer patients with brain metastases.. Journal of Clinical Oncology. 40(4_suppl). 341–341.
2.
Sun, James, Dung‐Tsa Chen, Jiannong Li, et al.. (2019). Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk. Journal of Surgical Research. 245. 153–162. 1 indexed citations
3.
Chen, Yi, D. Britton, Elizabeth R. Wood, et al.. (2017). Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors. Methods in molecular biology. 1788. 251–268. 2 indexed citations
4.
Minton, Susan, Charles Cox, Tammy Bowman, et al.. (2006). Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression. Clinical Cancer Research. 12(1). 20–28. 205 indexed citations
5.
Gonciarz, Maciej, et al.. (2006). Helicobacter pylori in liver diseases.. PubMed. 57 Suppl 3. 155–61. 8 indexed citations
6.
Zhou, Jun, Liang Nong, Marek Wloch, et al.. (2001). Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer. 34(3). 341–350. 53 indexed citations
7.
Kang, Jimmy J.H., et al.. (1998). Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes.. PubMed. 4(4). 879–86. 63 indexed citations
8.
Mao, Weiguang, Rosalyn Irby, Domenico Coppola, et al.. (1997). Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene. 15(25). 3083–3090. 171 indexed citations
9.
Vadas, Peter, Brigitte Grouix, E. Stefanski, et al.. (1997). Coordinate expression of group II phospholipase A2 and the acute-phase proteins haptoglobin (HP) and α1-anti-chymotrypsin (ACH) by HepG2 cells. Clinical & Experimental Immunology. 108(1). 175–180. 7 indexed citations
10.
Yeatman, Timothy J., Michael L. Cher, Weiguang Mao, Marek Wloch, & Thomas A. Tedesco. (1996). Identification of genetic alterations associated with the process of human experimental colon cancer liver metastasis in the nude mouse. Clinical & Experimental Metastasis. 14(3). 246–252. 14 indexed citations
11.
Vadas, Peter, Eva Stefanski, Marek Wloch, et al.. (1996). Secretory Non‐Pancreatic Phospholipase A2 and cyclooxygenase‐2 Expression by Tracheobronchial Smooth Muscle Cells. European Journal of Biochemistry. 235(3). 557–563. 38 indexed citations
12.
Pruzanski, W., Brian P. Kennedy, H. van den Bosch, et al.. (1995). Tenidap sodium inhibits secretory non‐pancreatic phospholipase A2 synthesis by foetal rat calvarial osteoblasts. Mediators of Inflammation. 4(1). 67–70. 3 indexed citations
13.
Pruzanski, W., Earl R. Bogoch, Alan Katz, et al.. (1995). Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.. PubMed. 22(11). 2114–9. 13 indexed citations
14.
Pruzanski, W., Earl R. Bogoch, Marek Wloch, & Peter Vadas. (1991). The role of phospholipase A2 in the physiopathology of osteoarthritis.. PubMed. 27. 117–9. 16 indexed citations
15.
Bogoch, Earl R., et al.. (1991). Enzymatic activity and distribution of phospholipase A2 in human cartilage. Life Sciences. 48(25). 2457–2462. 21 indexed citations
16.
Pruzanski, W., Earl R. Bogoch, E. Stefanski, Marek Wloch, & Peter Vadas. (1990). Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes.. PubMed. 17(10). 1386–91. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026